Contact Now
Please Leave Us A Message
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shaanxi Kaishi Biotechnology Co., Ltd
Product Description
Paclitaxel 98% is a high-purity pharmaceutical active pharmaceutical ingredient (API) widely used in oncology drug development and sterile injectable chemotherapy formulations. It is a naturally derived diterpenoid compound originally extracted from Taxus species and remains one of the most important anticancer agents in modern pharmaceutical manufacturing.
As global demand increases for advanced Pharmaceutical Enzymes, Nutritional Ingredients, and oncology-grade APIs, Paclitaxel 98% continues to play a critical role in GMP-certified pharmaceutical production, CDMO manufacturing, and injectable drug supply chains.
Content Note: Prepared by our technical team based on peer-reviewed scientific literature. This content is intended for industrial and research use only and complies with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in Journal of Clinical Oncology (1998), paclitaxel demonstrated significant therapeutic activity in patients with ovarian and breast cancer as part of combination chemotherapy regimens.
According to a study in The New England Journal of Medicine (1994), paclitaxel showed clinically meaningful responses in previously treated ovarian cancer patients, establishing its role as a key chemotherapeutic agent.
Paclitaxel 98% is manufactured under strict GMP-controlled conditions to ensure consistent purity, stability, and pharmaceutical-grade compliance for global markets.
| Parameter | Specification |
|---|---|
| Active Ingredient | Paclitaxel |
| Purity | ≥ 98% |
| Appearance | White to off-white crystalline powder |
| Test Method | HPLC |
| Form | API powder / injectable intermediate |
| Storage | 2–8°C, protected from light and moisture |
The quality of Paclitaxel 98% depends on extraction efficiency, purification technology, and GMP-certified production systems. Advanced manufacturing ensures high bioactivity and consistent batch quality.
| Production Stage | Quality Impact |
|---|---|
| Plant extraction (Taxus species) | Maintains natural molecular structure and potency |
| Multi-stage chromatographic purification | Reduces impurities and improves safety profile |
| Sterile processing and crystallization | Enhances stability for injectable formulations |
| API | Mechanism | Clinical Application |
|---|---|---|
| Paclitaxel | Microtubule stabilization | Breast, ovarian, lung cancers |
| Docetaxel | Microtubule stabilization | Solid tumor chemotherapy |
| Doxorubicin | DNA intercalation | Broad oncology treatment |
Paclitaxel 98% is widely used in pharmaceutical oncology manufacturing and clinical drug development programs.
It is also applied in research involving Plant Extracts , Standardized Extracts, Herbal Extracts , Nutritional Ingredients, and Antioxidants for pharmaceutical innovation and formulation science.
We supply Paclitaxel 98% under strict GMP-certified systems with full regulatory support for global pharmaceutical markets.
It is used as an active pharmaceutical ingredient in chemotherapy drug production for cancer treatment.
Yes, it is commonly processed into sterile injectable dosage forms under GMP conditions.
The standard purity is ≥98%, confirmed by HPLC testing methods.
It should be stored at 2–8°C in a sealed, light-protected environment.
Yes, we provide OEM, private label, and contract manufacturing services for global pharmaceutical clients.
Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.